- Home
- CEPU vs IDYA Comparison
CEPU vs IDYA Comparison
Compare CEPU & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CEPU
- IDYA
- Stock Information
- Founded
- CEPU 1989
- IDYA 2015
- Country
- CEPU Argentina
- IDYA United States
- Employees
- CEPU N/A
- IDYA N/A
- Industry
- CEPU Electric Utilities: Central
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- CEPU Utilities
- IDYA Health Care
- Exchange
- CEPU Nasdaq
- IDYA Nasdaq
- Market Cap
- CEPU 1.8B
- IDYA 1.9B
- IPO Year
- CEPU 2018
- IDYA 2019
- Fundamental
- Price
- CEPU $11.80
- IDYA $21.92
- Analyst Decision
- CEPU Hold
- IDYA Strong Buy
- Analyst Count
- CEPU 1
- IDYA 13
- Target Price
- CEPU $12.00
- IDYA $53.42
- AVG Volume (30 Days)
- CEPU 208.7K
- IDYA 1.0M
- Earning Date
- CEPU 08-08-2025
- IDYA 08-05-2025
- Dividend Yield
- CEPU 2.63%
- IDYA N/A
- EPS Growth
- CEPU N/A
- IDYA N/A
- EPS
- CEPU 0.06
- IDYA N/A
- Revenue
- CEPU $697,204,690.00
- IDYA $7,000,000.00
- Revenue This Year
- CEPU $26.57
- IDYA $101.20
- Revenue Next Year
- CEPU N/A
- IDYA $286.70
- P/E Ratio
- CEPU $20.49
- IDYA N/A
- Revenue Growth
- CEPU N/A
- IDYA N/A
- 52 Week Low
- CEPU $7.07
- IDYA $13.45
- 52 Week High
- CEPU $16.60
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- CEPU 45.90
- IDYA 57.07
- Support Level
- CEPU $11.49
- IDYA $20.50
- Resistance Level
- CEPU $12.07
- IDYA $22.86
- Average True Range (ATR)
- CEPU 0.51
- IDYA 0.98
- MACD
- CEPU -0.04
- IDYA -0.17
- Stochastic Oscillator
- CEPU 31.99
- IDYA 60.09
About CEPU Central Puerto S.A. (each represents ten)
Central Puerto SA is a power generation company. It is mainly engaged in electric power generation and commercialization. The company is also involved in the natural gas distribution public sector service in the Cuyo and Centro regions in Argentina. The Group has four reporting segments which includes electric power generation from conventional sources, electric power generation from renewable sources, natural gas transport and distribution, and forest activity.. The company derives maximum revenue from Electric Power Generation from conventional sources segment.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.